71PD REVERSIBLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASES INIHIBITORS (REGFR-TKIS), ERLOTINIB OR GEFITINIB, COMPARED TO CHEMOTHERAPY (CHT) IN PREVIOUSLY TREATED METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): A META-ANALYSIS
Titel:
71PD REVERSIBLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASES INIHIBITORS (REGFR-TKIS), ERLOTINIB OR GEFITINIB, COMPARED TO CHEMOTHERAPY (CHT) IN PREVIOUSLY TREATED METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): A META-ANALYSIS
Auteur:
Pochesci, A. Trenta, P. Iacovelli, R. Palleschi, M. Prete, A.A. Magri, V. Mosillo, C. Pellegrino, D. De Benedetto, A. Cortesi, E.